KR100387347B1 - 피페리딘 유도체 및 그의 제조 방법 - Google Patents

피페리딘 유도체 및 그의 제조 방법 Download PDF

Info

Publication number
KR100387347B1
KR100387347B1 KR1019950705909A KR19950705909A KR100387347B1 KR 100387347 B1 KR100387347 B1 KR 100387347B1 KR 1019950705909 A KR1019950705909 A KR 1019950705909A KR 19950705909 A KR19950705909 A KR 19950705909A KR 100387347 B1 KR100387347 B1 KR 100387347B1
Authority
KR
South Korea
Prior art keywords
acid
piperidinyl
mixture
substantially pure
hydroxybutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1019950705909A
Other languages
English (en)
Korean (ko)
Other versions
KR960703398A (ko
Inventor
토마스 이. 담브라
Original Assignee
알바니 몰레큘라 리써치, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22176189&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100387347(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 알바니 몰레큘라 리써치, 인크. filed Critical 알바니 몰레큘라 리써치, 인크.
Priority to KR10-2002-7009756A priority Critical patent/KR100387348B1/ko
Publication of KR960703398A publication Critical patent/KR960703398A/ko
Application granted granted Critical
Publication of KR100387347B1 publication Critical patent/KR100387347B1/ko
Assigned to 에이엠알 테크놀로지, 인크. reassignment 에이엠알 테크놀로지, 인크. 권리의 전부이전등록 Assignors: 알바니 몰레큘라 리써치, 인크.
Assigned to 알바니 몰레큘라 리써치, 인크. reassignment 알바니 몰레큘라 리써치, 인크. 권리의 전부이전등록 Assignors: 에이엠알 테크놀로지, 인크.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/86—Unsaturated compounds containing keto groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019950705909A 1993-06-24 1994-06-21 피페리딘 유도체 및 그의 제조 방법 Expired - Lifetime KR100387347B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2002-7009756A KR100387348B1 (ko) 1993-06-24 1994-06-21 피페리딘 유도체의 제조 방법

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8310293A 1993-06-24 1993-06-24
US08/083,102 1993-06-24
US08/083102 1993-06-24

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR10-2002-7009756A Division KR100387348B1 (ko) 1993-06-24 1994-06-21 피페리딘 유도체의 제조 방법

Publications (2)

Publication Number Publication Date
KR960703398A KR960703398A (ko) 1996-08-17
KR100387347B1 true KR100387347B1 (ko) 2003-11-28

Family

ID=22176189

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019950705909A Expired - Lifetime KR100387347B1 (ko) 1993-06-24 1994-06-21 피페리딘 유도체 및 그의 제조 방법
KR10-2002-7009756A Expired - Lifetime KR100387348B1 (ko) 1993-06-24 1994-06-21 피페리딘 유도체의 제조 방법

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR10-2002-7009756A Expired - Lifetime KR100387348B1 (ko) 1993-06-24 1994-06-21 피페리딘 유도체의 제조 방법

Country Status (16)

Country Link
US (9) US5750703A (https=)
EP (4) EP1369409B1 (https=)
JP (4) JP3034047B2 (https=)
KR (2) KR100387347B1 (https=)
AT (3) ATE254594T1 (https=)
AU (1) AU670004B2 (https=)
CA (1) CA2147126C (https=)
DE (3) DE69415319T2 (https=)
DK (3) DK0703902T3 (https=)
ES (3) ES2129130T3 (https=)
FI (1) FI109691B (https=)
HU (1) HU226559B1 (https=)
NO (2) NO308599B1 (https=)
NZ (1) NZ268513A (https=)
PT (2) PT1026147E (https=)
WO (1) WO1995000482A1 (https=)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1688142A1 (en) * 1992-08-03 2006-08-09 Sepracor Inc. Terfenadine carboxylate and the treatment of dermal irritation
EP1369409B1 (en) 1993-06-24 2006-04-05 AMR Technology, Inc. Process for preparing compounds useful as intermediates
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
DK0705245T3 (da) 1993-06-25 2003-04-14 Merrell Pharma Inc Nye mellemprodukter til fremstilling af antihistaminiske 4-diphenylmethyl/diphenylmethoxy-piperidinforbindelser
EP1178041A1 (en) * 1994-05-18 2002-02-06 Aventis Pharmaceuticals Inc. Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
DK0812195T3 (da) 1995-02-28 2003-03-03 Aventis Pharma Inc Farmaceutisk sammensætning til piperidinoalkanolforbindelser
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5925761A (en) * 1997-02-04 1999-07-20 Sepracor Inc. Synthesis of terfenadine and derivatives
ZA985939B (en) 1997-07-08 2000-01-10 Aristocrat Leisure Ind Pty Ltd Slot machine game and system with improved jackpot feature.
JP4344405B2 (ja) * 1997-08-26 2009-10-14 アベンティス・ファーマスーティカルズ・インコーポレイテッド ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物
US6194431B1 (en) 1998-04-14 2001-02-27 Paul D. Rubin Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
US6730791B2 (en) 1998-07-02 2004-05-04 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
BR9911794A (pt) * 1998-07-02 2001-03-27 Aventis Pharma Inc Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos
AU2007200674C1 (en) * 1998-07-02 2011-02-24 Aventisub Llc Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6362375B1 (en) 1999-12-03 2002-03-26 College Of The Holy Cross Process for the preparation of aryl ketones generating reduced amounts of toxic byproducts
US6613906B1 (en) 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
GB0018691D0 (en) * 2000-07-28 2000-09-20 Rolabo Sl Process
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
US20030021849A1 (en) * 2001-04-09 2003-01-30 Ben-Zion Dolitzky Polymorphs of fexofenadine hydrochloride
IL158334A0 (en) * 2001-04-09 2004-05-12 Teva Pharma Polymorphs of fexofenadine hydrochloride
US6743941B2 (en) 2001-06-15 2004-06-01 Aventis Pharma Deutschland Gmbh Process for the production of piperidine derivatives
EP1401815A1 (en) * 2001-06-25 2004-03-31 Aurobindo Pharma Limited Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-alpha,alpha-dimethylphenyl acetic acid
US6593499B2 (en) * 2001-08-29 2003-07-15 Council Of Scientific & Industrial Research Process for the preparation of phenyl ketones
CA2465913A1 (en) * 2001-11-08 2003-05-15 Judith Aronhime Polymorphs of fexofenadine base
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
US20040044038A1 (en) * 2002-06-10 2004-03-04 Barnaba Krochmal Polymorphic form XVI of fexofenadine hydrochloride
US20050065183A1 (en) * 2003-07-31 2005-03-24 Indranil Nandi Fexofenadine composition and process for preparing
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
JP2007532687A (ja) * 2004-04-26 2007-11-15 テバ ファーマシューティカル インダストリーズ リミティド フェキソフェナジン塩酸塩の結晶形およびその製造方法
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
JP2008514641A (ja) * 2004-09-28 2008-05-08 テバ ファーマシューティカル インダストリーズ リミティド 結晶形フェキソフェナジン、およびその調製方法
US7841939B2 (en) 2005-09-09 2010-11-30 Igt Server based gaming system having multiple progressive awards
US7568973B2 (en) 2005-09-09 2009-08-04 Igt Server based gaming system having multiple progressive awards
JP2009514969A (ja) 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
US7780520B2 (en) 2006-03-15 2010-08-24 Igt Gaming device having multiple different types of progressive awards
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
US8070597B2 (en) 2006-08-03 2011-12-06 Igt Gaming device and method having multiple progressive award levels and a secondary game for advancing through the progressive award levels
US9047733B2 (en) 2006-11-08 2015-06-02 Igt Gaming system and method for providing multiple level progressive awards with increased odds of winning higher level progressive awards
US20090306135A1 (en) 2008-03-24 2009-12-10 Mukesh Kumar Sharma Stable amorphous fexofenadine hydrochloride
WO2009136412A2 (en) * 2008-04-25 2009-11-12 Matrix Laboratories Limited PROCESS FOR PREPARATION OF 4-[4-(4-(HYDROXYDIPHENYLMETHYL)- 1-PIPERIDINYL]-1-OXOBUTYL]-α,α-DIMETHYLBENZENE ACETIC ACID METHYL ESTER AND USE THEREOF
EP3067352A3 (en) * 2008-05-07 2016-10-19 Cardioxyl Pharmaceuticals Inc. Novel nitroso compounds as nitroxyl donors and methods of use thereof
CA2724607A1 (en) * 2008-05-30 2009-12-31 Fairfield Clinical Trials, Llc Method and composition for skin inflammation and discoloration
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
EP2289867A3 (en) 2009-08-19 2012-04-25 Jubilant Organosys Limited A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
CN102070512B (zh) * 2009-11-21 2014-11-19 浙江华海药业股份有限公司 一种高纯度非索非那定及其中间体的合成路线与制备方法
US20110160200A1 (en) * 2009-11-23 2011-06-30 Cardioxyl Pharmaceuticals, Inc. Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension
CN102962288A (zh) * 2012-11-21 2013-03-13 苏州江南航天机电工业有限公司 圆弧状大板与直板拼接工艺
ITMI20131652A1 (it) * 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
PT3365327T (pt) * 2015-10-22 2020-02-06 Sanofi Aventis Deutschland Processo para a preparação de fexofenadina e de intermediários usados no mesmo
CN116178222B (zh) * 2021-11-29 2025-04-25 上海晓明检测技术服务有限公司 环磺酮代谢物m9的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4028404A (en) * 1967-07-31 1977-06-07 Allen & Hanburys Limited Acetic acid derivatives
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
US3839431A (en) * 1970-07-13 1974-10-01 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
US3898271A (en) * 1971-06-08 1975-08-05 Squibb & Sons Inc Cyclopropylmethylphenylacetic acids and derivatives
BE794596A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation
US3965257A (en) * 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
BE794598A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3941795A (en) * 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US3931197A (en) * 1974-02-08 1976-01-06 Richardson-Merrell Inc. Substituted piperidine derivatives
US3946022A (en) * 1974-03-04 1976-03-23 Richardson-Merrell Inc. Piperidine derivatives
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US3922276A (en) * 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines
DD141422A5 (de) * 1978-01-27 1980-04-30 Schering Ag Verfahren zur herstellung von phenylessigsaeure-derivaten
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
DK0635004T3 (da) * 1992-04-10 2002-11-11 Merrell Pharma Inc 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
EP1688142A1 (en) * 1992-08-03 2006-08-09 Sepracor Inc. Terfenadine carboxylate and the treatment of dermal irritation
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
EP1369409B1 (en) * 1993-06-24 2006-04-05 AMR Technology, Inc. Process for preparing compounds useful as intermediates
US6147216A (en) 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
DK0705245T3 (da) * 1993-06-25 2003-04-14 Merrell Pharma Inc Nye mellemprodukter til fremstilling af antihistaminiske 4-diphenylmethyl/diphenylmethoxy-piperidinforbindelser
US7022882B2 (en) * 2000-10-06 2006-04-04 The Regents Of The University Of California NMDA receptor channel blocker with neuroprotective activity

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives

Also Published As

Publication number Publication date
JPH11236373A (ja) 1999-08-31
ATE174589T1 (de) 1999-01-15
EP0703902A4 (https=) 1996-04-10
EP0723958A1 (en) 1996-07-31
US7238834B2 (en) 2007-07-03
EP1369409B1 (en) 2006-04-05
EP1026147A1 (en) 2000-08-09
JPH08511806A (ja) 1996-12-10
HU226559B1 (en) 2009-03-30
US20080227983A1 (en) 2008-09-18
EP1026147B1 (en) 2003-11-19
FI109691B (fi) 2002-09-30
JP3034047B2 (ja) 2000-04-17
DE69433346T2 (de) 2004-09-09
CA2147126C (en) 1999-08-24
ES2211444T3 (es) 2004-07-16
DK1026147T3 (da) 2004-03-22
CA2147126A1 (en) 1995-01-05
EP0703902B1 (en) 1998-12-16
US5750703A (en) 1998-05-12
ES2129130T3 (es) 1999-06-01
KR100387348B1 (ko) 2003-06-12
NO994582D0 (no) 1999-09-21
US7390906B2 (en) 2008-06-24
JP3658291B2 (ja) 2005-06-08
DE69415319T2 (de) 1999-06-10
FI956270A0 (fi) 1995-12-27
DE69434696T2 (de) 2006-11-16
DK1369409T3 (da) 2006-08-14
PT1369409E (pt) 2006-08-31
JP3195297B2 (ja) 2001-08-06
ATE254594T1 (de) 2003-12-15
EP0703902A1 (en) 1996-04-03
NO308599B1 (no) 2000-10-02
NZ268513A (en) 1996-09-25
KR960703398A (ko) 1996-08-17
US5663412A (en) 1997-09-02
PT1026147E (pt) 2004-04-30
US20060052610A1 (en) 2006-03-09
NO955023D0 (no) 1995-12-12
AU7174894A (en) 1995-01-17
WO1995000482A1 (en) 1995-01-05
DK0703902T3 (da) 1999-08-23
HUT73235A (en) 1996-07-29
NO994582L (no) 1995-12-12
JP2001031650A (ja) 2001-02-06
HU9503719D0 (en) 1996-02-28
FI956270L (fi) 1995-12-27
US5994549A (en) 1999-11-30
DE69433346D1 (de) 2003-12-24
US5589487A (en) 1996-12-31
EP1369409A1 (en) 2003-12-10
ES2261871T3 (es) 2006-11-16
US5578610A (en) 1996-11-26
NO955023L (no) 1995-12-12
DE69434696D1 (de) 2006-05-18
JP4124998B2 (ja) 2008-07-23
AU670004B2 (en) 1996-06-27
US5581011A (en) 1996-12-03
US20060241303A1 (en) 2006-10-26
DE69415319D1 (de) 1999-01-28
ATE322473T1 (de) 2006-04-15
JP2002212166A (ja) 2002-07-31

Similar Documents

Publication Publication Date Title
KR100387347B1 (ko) 피페리딘 유도체 및 그의 제조 방법
KR100591212B1 (ko) 피페리딘 유도체를 제조하기 위한 중간체
KR100573943B1 (ko) 피페리딘 유도체를 제조하기 위한 중간체
US7022880B2 (en) Piperidine derivatives and process for their production
AU729549B2 (en) Piperidine derivatives and process for their production
CA2181089C (en) Piperidine derivatives and process for their production
AU699799B2 (en) Piperidine derivatives and process for their production
HK1062672A (en) Process for preparing compounds useful as intermediates
NZ286116A (en) Substantially pure diphenylmethyl piperidin-1-yl substituted dimethylphenylacetic acid and esters; pharmaceutical compositions

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19951223

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19990618

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20010629

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20020328

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20010629

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20020628

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20020328

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20030326

Appeal identifier: 2002101002542

Request date: 20020628

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20020729

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20020628

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20020628

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 19990618

Patent event code: PB09011R02I

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20020923

Patent event code: PE09021S01D

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20030213

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20030326

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20020902

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20030530

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20030602

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20060525

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20070523

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20080522

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20090525

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 20100525

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20110421

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 20120503

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20130502

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20130502

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20140508

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20140508

Start annual number: 12

End annual number: 12

EXPY Expiration of term
PC1801 Expiration of term

Termination date: 20141221

Termination category: Expiration of duration